Packages (Simulation)
Reagent Preparation
Image (I)
-
Results demonstration
Image (II)
-
Typical Standard Curve
Quality Guarantee
Instruction Manual
Certificate
Multiplex Assay Kit for Uroplakin 2 (UPK2) ,etc. by FLIA (Flow Luminescence Immunoassay)
UPII; Uroplakin II
(Note: Up to 8-plex in one testing reaction)
- Product No.LMF561Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeTissue homogenates, cell lysates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length4h
- Detection Range0.01-10ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.003 ng/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 437
US$ 454
US$ 479
US$ 512
US$ 546
US$ 596
US$ 672
US$ 840
Add to Price Calculator
Result
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Uroplakin 2 (UPK2).
No significant cross-reactivity or interference between Uroplakin 2 (UPK2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Uroplakin 2 (UPK2) and the recovery rates were calculated by comparing the measured value to the expected amount of Uroplakin 2 (UPK2) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 81-95 | 91 |
| EDTA plasma(n=5) | 81-101 | 94 |
| heparin plasma(n=5) | 97-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Uroplakin 2 (UPK2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Uroplakin 2 (UPK2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Uroplakin 2 (UPK2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 82-90% | 88-98% | 94-102% | 86-98% |
| EDTA plasma(n=5) | 89-97% | 84-94% | 80-93% | 78-98% |
| heparin plasma(n=5) | 93-104% | 96-103% | 93-101% | 87-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:UPK2) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| BioMed Research International | Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer |
| . | Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases 34944460 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF561Hu01 | Recombinant Uroplakin 2 (UPK2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF561Hu01 | Polyclonal Antibody to Uroplakin 2 (UPK2) | WB,IHC |
| LAF561Hu61 | Cy3-Linked Polyclonal Antibody to Uroplakin 2 (UPK2) | WB; IHC; ICC; IF. |
| SEF561Hu | ELISA Kit for Uroplakin 2 (UPK2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF561Hu | Multiplex Assay Kit for Uroplakin 2 (UPK2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
| CMF561Hu | Multiplex Assay Kit for Uroplakin 2 (UPK2) ,etc. by CBA (Cytometric Bead Array) | FLIA Kit for Antigen Detection. |